Merck (MRK) Raw Materials (2009 - 2012)

Merck (MRK) posted quarterly Raw Materials of $265.0 million for Q2 2012, down 11.07% YoY from $298.0 million in Q3 2011, and down 14.52% sequentially from $310.0 million in Q1 2012.

Merck (MRK) Raw Materials (2009 - 2012) Analysis & Trends

Merck has disclosed Raw Materials across 4 years of filings, most recently posting $265.0 million for Q2 2012.

  • In Q2 2012, Raw Materials fell 11.07% year-over-year to $265.0 million; the TTM figure through Jun 2012 stood at $265.0 million (down 11.07% YoY), while the FY2011 annual figure was $297.0 million, down 5.71% from the prior year.
  • Raw Materials declined to $265.0 million in Q2 2012, from $310.0 million in the prior quarter.
  • Over the last five years, Raw Materials for MRK reached as high as $5.8 billion in Q3 2011 and fell as low as $265.0 million in Q2 2012.
  • The 4-year median for Raw Materials is $312.5 million (2010), against an average of $1.4 billion.
  • The widest YoY moves for Raw Materials: up 1694.0% in 2011, down 94.39% in 2011.
  • A 4-year view of Raw Materials shows it stood at $323.0 million in 2009, then slipped by 2.48% to $315.0 million in 2010, then dropped by 5.71% to $297.0 million in 2011, then dropped by 10.77% to $265.0 million in 2012.
  • According to Business Quant data, Raw Materials over the past three periods registered $265.0 million, $310.0 million, and $297.0 million for Q2 2012, Q1 2012, and Q4 2011 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Jun 30, 2012 265.00 Mn
Mar 31, 2012 310.00 Mn
Dec 31, 2011 297.00 Mn
Sep 30, 2011 5.80 Bn
Jun 30, 2011 298.00 Mn
Mar 31, 2011 306.00 Mn
Dec 31, 2010 315.00 Mn
Sep 30, 2010 323.30 Mn
Jun 30, 2010 5.31 Bn
Dec 31, 2009 323.00 Mn